Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/8047
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMiltiadous, G.en
dc.contributor.authorHatzivassiliou, M.en
dc.contributor.authorLiberopoulos, E.en
dc.contributor.authorBairaktari, E.en
dc.contributor.authorTselepis, A.en
dc.contributor.authorCariolou, M.en
dc.contributor.authorElisaf, M.en
dc.date.accessioned2015-11-24T16:38:27Z-
dc.date.available2015-11-24T16:38:27Z-
dc.identifier.issn0939-4753-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8047-
dc.rightsDefault Licence-
dc.subjecthdl-cholesterolen
dc.subjectgenesen
dc.subjectapolipoprotein een
dc.subjectapolipoprotein a iven
dc.subjectcholesterol ester transfer proteinen
dc.subjectapolipoprotein-a-iven
dc.subjecthigh-density-lipoproteinsen
dc.subjecttransfer protein-activityen
dc.subjectfrequencyen
dc.subjectheterogeneityen
dc.subjectsitesen
dc.subjectlocusen
dc.subjectcetpen
dc.titleGene polymorphisms affecting HDL-cholesterol levels in the normolipidemic populationen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDOI 10.1016/j.numced.2004.09.004-
heal.identifier.secondary<Go to ISI>://000230318700010-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0939475305000451/1-s2.0-S0939475305000451-main.pdf?_tid=40233cf43599e4275ef2af4ab6b5cf42&acdnat=1333111627_b1831f90cee312120e31ab2f6fb5e283-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2005-
heal.abstractBackground and Aim: HDL-cholesterot (HDL-C) is inversely related to the risk of ischemic heart disease. Many genes are reported to affect HDL-C serum levels in both hyperlipidemic and normolipidemic populations, though the data are controversial. We examined the effect of common gene polymorphisms known to interfere with HDL-C metabolism (apolipoprotein E, cholesterol ester transfer protein and apolipoprotein A-IV gene polymorphisms) on HDL-C plasma levels in normolipidemic subjects. Methods and results: The study population consisted of 200 normolipidernic individuals visiting our clinic for a routine check-up. None of the above gene polymorphisms affected HDL-C levels in our population. However, participants carrying the atlete E4 of the apolipoprotein (apo) E gene, the allele B1 of the TaqIB polymorphisms in the cholesterol ester transfer protein (CETP) gene and the allele T of the apoA-IV gene (A to T polymorphism at site 347) (n=28) had statistically significantly tower HDL-C levels compared to those not carrying the above allele combination (0.99+0.33 vs 1.28 0.35 mmol/L, p=0.04). Conclusion: In this study, we describe a subgroup of normolipidemic individuals with low HDL-C levels due to genetic variability, and we discuss the underlying possible mechanisms involved. (c) 2005 Elsevier Ltd. All. rights reserved.en
heal.journalNameNutrition Metabolism and Cardiovascular Diseasesen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Files in This Item:
File Description SizeFormat 
Miltiadous-2005-Gene polymorphisms a.pdf113.06 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons